Undertreatment of Patients with Myelodysplastic Syndromes (MDS): Analysis of an Electronic Medical Records (EMR) Database Cohort of US MDS Patients von Steensma, D.P, Scott, B.L, Ma, X, Fliss, A, Kiselev, P, Swern, A.S, Sugrue, M.M

Volltext

Current Diagnosis Patterns for Acute Myeloid Leukemia: Concordance Between Clinical Practice (Connect® Disease Registry) and Who 2008 Recommendations von George, T.I, Erba, H.P, Pollyea, D.A, Abedi, M, Roboz, G.J, Thompson, M.A, Fliss, A, Swern, A.S, Nifenecker, M, Kiselev, P, Sugrue, M.M, Foucar, K

Volltext

217 DEFINING LIKELIHOOD OF FUTURE RESPONSE IN PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH LENALIDOMIDE von Gerds, A.T, List, A.F, Giagounidis, A, Hellström-Lindberg, E, Li, J. Shiansong, Swern, A.S, Sugrue, M.M, Fenaux, P, Sekeres, M.A

Volltext

115 MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS EPO ON RBC TRANSFUSION INDEPENDENCE (RBC-TI) IN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MDS WITHOUT DEL(5Q) von Santini, V, Li, J.S, Swern, A.S, Almeida, A, Giagounidis, A, Fu, T, Hoenekopp, A, Beach, C.L, Skikne, B, Fenaux, P

Volltext

Montelukast and bronchial inflammation in asthma: A randomised, double-blind placebo-controlled trial von Ramsay, C.F, Sullivan, P, Gizycki, M, Wang, D, Swern, A.S, Barnes, N.C, Reiss, T.F, Jeffery, P.K

Volltext

PSY59 Variation in Health-Related Quality of Life Associated With Changes in Transfusion Status of Patients With Myelodysplastic Syndromes Across Six Months of Treatment With Azaci... von Pashos, C.L, Grinblatt, D.L, Sekeres, M.A, Komrokji, R.S, Narang, M, Swern, A.S, Street, T.K, Sullivan, K.A, Harding, G, Khan, Z.M

Volltext

PCN103 Variation in Health-Related Quality of Life by Age Among Patients With Chronic Lymphocytic Leukemia von Pashos, C.L, Flowers, C.R, Weiss, M, Lamanna, N, Farber, C, Kipps, T.J, Lerner, S, Kay, N, Sharman, J, Grinblatt, D.L, Flinn, I.W, Kozloff, M.F, Swern, A.S, Khan, Z, Street, T.K, Sullivan, K.A, Harding, G, Keating, M.J

Volltext

PCN142 Association of Health-Related Quality of Life Among Patients With Multiple Myeloma With Insurance Coverage von Pashos, C.L, Durie, B.G, Rifkin, R.M, Abonour, R, Fonseca, R, Gasparetto, C, Mehta, J, Narang, M, Shah, J.J, Terebelo, H.R, Thomas, S, Toomey, K, Swern, A.S, Harding, G, Yu, R, Sullivan, K.A, Street, T.K, Khan, Z.M

Volltext

122 - Undertreatment of Patients with Myelodysplastic Syndromes (MDS): Analysis of an Electronic Medical Records (EMR) Database Cohort of US MDS Patients von Steensma, D.P., Scott, B.L., Ma, X., Fliss, A., Kiselev, P., Swern, A.S., Sugrue, M.M.

Volltext

Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myeloma von Dimopoulos, M A, Hussein, M, Swern, A S, Weber, D

Volltext

170 - Current Diagnosis Patterns for Acute Myeloid Leukemia: Concordance Between Clinical Practice (Connect® Disease Registry) and Who 2008 Recommendations von George, T.I., Erba, H.P., Pollyea, D.A., Abedi, M., Roboz, G.J., Thompson, M.A., Fliss, A., Swern, A.S., Nifenecker, M., Kiselev, P., Sugrue, M.M., Foucar, K.

Volltext

PS1500 HEALTHCARE RESOURCE UTILIZATION (HCRU) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) ACUTE MYELOID LEUKEMIA (AML) TREATED IN THE CONNECT® MDS/AML DISEASE REGISTRY von Mukherjee, S., Abedi, M., Erba, H.P., Pollyea, D.A., Roboz, G.J., Thompson, M.A., Louis, C.U., Flick, E.D., Nifenecker, M., Kiselev, P., Swern, A.S., Cogle, C.R.

Volltext